Download application/pdf, 104.05 KB

Henrik Grönberg, publications
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
Bjermer L, Gronberg H, Roos G, Henriksson R. Interleukin-2-administration
intravenously and intrapleurally in a patient with primary pulmonary adenocarcinoma.
Cellular responses in peripheral blood, intrapleural fluid and bronchoalveolar lavage.
Biotherapy. 1993;6(1):1-7.
Gronberg H, Bergh A, Damber JE, Jonsson H, Lenner P, Angstrom T. Prostate cancer in
northern Sweden. Incidence, survival and mortality in relation to tumour grade. Acta
Oncol. 1994;33(4):359-63.
Gronberg H, Damber JE, Jonsson H, Lenner P. Patient age as a prognostic factor in
prostate cancer. J Urol. 1994;152(3):892-5.
Gronberg H, Damber L, Damber JE. Studies of genetic factors in prostate cancer in a twin
population. J Urol. 1994;152(5 Pt 1):1484-7; discussion 7-9.
Friedrich B, Gronberg H, Landstrom M, Gullberg M, Bergh A. Differentiation-stage
specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma.
Prostate. 1995;27(2):102-9.
Damber JE, Gronberg H. [Mortality due to prostatic carcinoma in northern Sweden].
Urologe A. 1996;35(6):443-5.
Gronberg H, Damber JE, Damber L, Jonsson H. Re: Prostate cancer mortality in patients
surviving more than 10 years after diagnosis. J Urol. 1996;156(5):1785-6.
Gronberg H, Damber L, Damber JE. Familial prostate cancer in Sweden. A nationwide
register cohort study. Cancer. 1996;77(1):138-43.
Gronberg H, Damber L, Damber JE. Total food consumption and body mass index in
relation to prostate cancer risk: a case-control study in Sweden with prospectively
collected exposure data. J Urol. 1996;155(3):969-74.
Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, et al. Major susceptibility
locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science.
1996;274(5291):1371-4.
Gronberg H, Damber L, Damber JE, Iselius L. Segregation analysis of prostate cancer in
Sweden: support for dominant inheritance. Am J Epidemiol. 1997;146(7):552-7.
Gronberg H, Damber L, Jonson H, Damber JE. Prostate cancer mortality in northern
Sweden, with special reference to tumor grade and patient age. Urology. 1997;49(3):3748.
Gronberg H, Isaacs SD, Smith JR, Carpten JD, Bova GS, Freije D, et al. Characteristics
of prostate cancer in families potentially linked to the hereditary prostate cancer 1
(HPC1) locus. JAMA. 1997;278(15):1251-5.
Gronberg H, Xu J, Smith JR, Carpten JD, Isaacs SD, Freije D, et al. Early age at
diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus
(HPC1) on chromosome 1. Cancer Res. 1997;57(21):4707-9.
Damber L, Gronberg H, Damber JE. Familial prostate cancer and possible associated
malignancies: nation-wide register cohort study in Sweden. Int J Cancer. 1998;78(3):2937.
Gronberg H, Bergh A, Damber JE. [Gene for hereditary prostatic cancer has been located.
New possibilities for early identification of men at risk]. Lakartidningen.
1998;95(14):1522-5.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
Gronberg H, Damber L, Tavelin B, Damber JE. No difference in survival between
sporadic, familial and hereditary prostate cancer. Br J Urol. 1998;82(4):564-7.
Liu T, Stathopoulos P, Lindblom P, Rubio C, Wasteson Arver B, Iselius L, et al. MSH2
codon 322 Gly to Asp seems not to confer an increased risk for colorectal cancer
susceptibility. Eur J Cancer. 1998;34(12):1981.
Liu T, Wahlberg S, Rubio C, Holmberg E, Gronberg H, Lindblom A. DGGE screening of
mutations in mismatch repair genes (hMSH2 and hMLH1) in 34 Swedish families with
colorectal cancer. Clin Genet. 1998;53(2):131-5.
Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, et al. Evidence for a prostate
cancer susceptibility locus on the X chromosome. Nat Genet. 1998;20(2):175-9.
Ekman P, Gronberg H, Matsuyama H, Kivineva M, Bergerheim US, Li C. Links between
genetic and environmental factors and prostate cancer risk. Prostate. 1999;39(4):262-8.
Gronberg H, Smith J, Emanuelsson M, Jonsson BA, Bergh A, Carpten J, et al. In Swedish
families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome
1q24-25 is restricted to families with early-onset prostate cancer. Am J Hum Genet.
1999;65(1):134-40.
Gronberg H, Wiklund F, Damber JE. Age specific risks of familial prostate carcinoma: a
basis for screening recommendations in high risk populations. Cancer. 1999;86(3):47783.
Malmer B, Gronberg H, Bergenheim AT, Lenner P, Henriksson R. Familial aggregation
of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer.
1999;81(3):366-70.
Robertson JF, Jaeger W, Syzmendera JJ, Selby C, Coleman R, Howell A, et al. The
objective measurement of remission and progression in metastatic breast cancer by use of
serum tumour markers. European Group for Serum Tumour Markers in Breast Cancer.
Eur J Cancer. 1999;35(1):47-53.
Ahman AK, Jonsson BA, Damber JE, Bergh A, Emanuelsson M, Gronberg H. Low
frequency of allelic imbalance at the prostate cancer susceptibility loci HPC1 and 1p36 in
Swedish men with hereditary prostate cancer. Genes Chromosomes Cancer.
2000;29(4):292-6.
Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H, et al.
Risk perception, screening practice and interest in genetic testing among unaffected men
in families with hereditary prostate cancer. Eur J Cancer. 2000;36(2):235-41.
Gronberg H, Bergh A, Damber JE, Emanuelsson M. Cancer risk in families with
hereditary prostate carcinoma. Cancer. 2000;89(6):1315-21.
Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, et al. Somatic
deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer
susceptibility locus. Proc Natl Acad Sci U S A. 2000;97(17):9603-8.
Malmer B, Tavelin B, Henriksson R, Gronberg H. Primary brain tumours as second
primary: a novel association between meningioma and colorectal cancer. Int J Cancer.
2000;85(1):78-81.
Ahman AK, Jonsson BA, Damber JE, Bergh A, Gronberg H. Low frequency of
microsatellite instability in hereditary prostate cancer. BJU Int. 2001;87(4):334-8.
Andersen PM, Gronberg H, Franzen L, Funegard U. External radiation of the parotid
glands significantly reduces drooling in patients with motor neurone disease with bulbar
paresis. J Neurol Sci. 2001;191(1-2):111-4.
Benoit RM, Gronberg H, Naslund MJ. A quantitative analysis of the costs and benefits of
prostate cancer screening. Prostate Cancer Prostatic Dis. 2001;4(3):138-45.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
Cederquist K, Golovleva I, Emanuelsson M, Stenling R, Gronberg H. A population based
cohort study of patients with multiple colon and endometrial cancer: correlation of
microsatellite instability (MSI) status, age at diagnosis and cancer risk. Int J Cancer.
2001;91(4):486-91.
Gronberg H. Prostate cancer. A small organ with a vital function. Lancet. 2001;358
Suppl:S55.
Gronberg H, Ahman AK, Emanuelsson M, Bergh A, Damber JE, Borg A. BRCA2
mutation in a family with hereditary prostate cancer. Genes Chromosomes Cancer.
2001;30(3):299-301.
Huang J, Kuismanen SA, Liu T, Chadwick RB, Johnson CK, Stevens MW, et al. MSH6
and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer.
Cancer Res. 2001;61(4):1619-23.
Liu T, Chen J, Salahshor S, Kuismanen S, Holmberg E, Gronberg H, et al. Screening
families with endometrial and colorectal cancers for germline mutations. J Med Genet.
2001;38(9):E29.
Malmer B, Gronberg H, Andersson U, Jonsson BA, Henriksson R. Microsatellite
instability, PTEN and p53 germline mutations in glioma families. Acta Oncol.
2001;40(5):633-7.
Malmer B, Iselius L, Holmberg E, Collins A, Henriksson R, Gronberg H. Genetic
epidemiology of glioma. Br J Cancer. 2001;84(3):429-34.
Bergfeldt K, Rydh B, Granath F, Gronberg H, Thalib L, Adami HO, et al. Risk of ovarian
cancer in breast-cancer patients with a family history of breast or ovarian cancer: a
population-based cohort study. Lancet. 2002;360(9337):891-4.
Bratt O, Damber JE, Emanuelsson M, Gronberg H. Hereditary prostate cancer: clinical
characteristics and survival. J Urol. 2002;167(6):2423-6.
Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, et al. Germline mutations in
the ribonuclease L gene in families showing linkage with HPC1. Nat Genet.
2002;30(2):181-4.
Jonsson BA, Bergh A, Stattin P, Emmanuelsson M, Gronberg H. Germline mutations in
E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and
breast cancer. Int J Cancer. 2002;98(6):838-43.
Malmer B, Brannstrom T, Andersson U, Bergh K, Gronberg H, Henriksson R. Does a
low frequency of P53 and Pgp expression in familial glioma compared to sporadic
controls indicate biological differences? Anticancer Res. 2002;22(6C):3949-54.
Malmer B, Henriksson R, Gronberg H. Different aetiology of familial low-grade and
high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology.
2002;21(6):279-86.
Nilbert M, Gronberg H, Lindblom A. [Essential to discover hereditary colorectal and
endometrial cancer. Mutations in "HNPCC individuals" can cause several different
tumors]. Lakartidningen. 2002;99(34):3296-300.
Bratt O, Emanuelsson M, Gronberg H. Psychological aspects of screening in families
with hereditary prostate cancer. Scand J Urol Nephrol. 2003;37(1):5-9.
Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin-Stahl E. A systematic overview
of radiation therapy effects in rectal cancer. Acta Oncol. 2003;42(5-6):476-92.
Gronberg H. Prostate cancer epidemiology. Lancet. 2003;361(9360):859-64.
Gronberg H, Paulin L, Sen R. ITS probe development for specific detection of
Rhizoctonia spp. and Suillus bovinus based on Southern blot and liquid hybridizationfragment length polymorphism. Mycol Res. 2003;107(Pt 4):428-38.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
Li C, Gronberg H, Matsuyama H, Weber G, Nordenskjold M, Naito K, et al. Difference
between Swedish and Japanese men in the association between AR CAG repeats and
prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen
receptor gene. Int J Mol Med. 2003;11(4):529-33.
Malmer B, Henriksson R, Gronberg H. Familial brain tumours-genetics or environment?
A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain
tumour patients. Int J Cancer. 2003;106(2):260-3.
Thellenberg C, Malmer B, Tavelin B, Gronberg H. Second primary cancers in men with
prostate cancer: an increased risk of male breast cancer. J Urol. 2003;169(4):1345-8.
Wiklund F, Gillanders EM, Albertus JA, Bergh A, Damber JE, Emanuelsson M, et al.
Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive
evidence of linkage at 5q11.2 and 19p13.3. Prostate. 2003;57(4):290-7.
Wiklund F, Jonsson BA, Goransson I, Bergh A, Gronberg H. Linkage analysis of prostate
cancer susceptibility: confirmation of linkage at 8p22-23. Hum Genet. 2003;112(4):4148.
Cederquist K, Emanuelsson M, Goransson I, Holinski-Feder E, Muller-Koch Y,
Golovleva I, et al. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients
with double primary cancers of the colorectum and the endometrium: a population-based
study in northern Sweden. Int J Cancer. 2004;109(3):370-6.
Chang ET, Hedelin M, Adami HO, Gronberg H, Balter KA. Re: Zinc supplement use and
risk of prostate cancer. J Natl Cancer Inst. 2004;96(14):1108; author reply -9.
Gillanders EM, Xu J, Chang BL, Lange EM, Wiklund F, Bailey-Wilson JE, et al.
Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst.
2004;96(16):1240-7.
Hassler S, Sjolander P, Johansson R, Gronberg H, Damber L. Fatal accidents and suicide
among reindeer-herding Sami in Sweden. Int J Circumpolar Health. 2004;63 Suppl
2:384-8.
Jonsson BA, Adami HO, Hagglund M, Bergh A, Goransson I, Stattin P, et al. -160C/A
polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and
sporadic prostate cancer. Int J Cancer. 2004;109(3):348-52.
Lindmark F, Jonsson BA, Bergh A, Stattin P, Zheng SL, Meyers DA, et al. Analysis of
the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate
cancer. Prostate. 2004;59(2):132-40.
Lindmark F, Zheng SL, Wiklund F, Bensen J, Balter KA, Chang B, et al. H6D
polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.
J Natl Cancer Inst. 2004;96(16):1248-54.
Meuller J, Kanter-Smoler G, Nygren AO, Errami A, Gronberg H, Holmberg E, et al.
Identification of genomic deletions of the APC gene in familial adenomatous polyposis
by two independent quantitative techniques. Genet Test. 2004;8(3):248-56.
Sun J, Hedelin M, Zheng SL, Adami HO, Bensen J, Augustsson-Balter K, et al.
Interleukin-6 sequence variants are not associated with prostate cancer risk. Cancer
Epidemiol Biomarkers Prev. 2004;13(10):1677-9.
Wiklund F, Jonsson BA, Brookes AJ, Stromqvist L, Adolfsson J, Emanuelsson M, et al.
Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate
cancer. Clin Cancer Res. 2004;10(21):7150-6.
Zheng SL, Augustsson-Balter K, Chang B, Hedelin M, Li L, Adami HO, et al. Sequence
variants of toll-like receptor 4 are associated with prostate cancer risk: results from the
CAncer Prostate in Sweden Study. Cancer Res. 2004;64(8):2918-22.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
Cederquist K, Emanuelsson M, Wiklund F, Golovleva I, Palmqvist R, Gronberg H. Two
Swedish founder MSH6 mutations, one nonsense and one missense, conferring high
cumulative risk of Lynch syndrome. Clin Genet. 2005;68(6):533-41.
Chang ET, Hedelin M, Adami HO, Gronberg H, Balter KA. Alcohol drinking and risk of
localized versus advanced and sporadic versus familial prostate cancer in Sweden. Cancer
Causes Control. 2005;16(3):275-84.
Glimelius B, Dahl O, Cedermark B, Jakobsen A, Bentzen SM, Starkhammar H, et al.
Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the
Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol. 2005;44(8):90412.
Hassler S, Johansson R, Sjolander P, Gronberg H, Damber L. Causes of death in the Sami
population of Sweden, 1961-2000. Int J Epidemiol. 2005;34(3):623-9.
Lindmark F, Zheng SL, Wiklund F, Balter KA, Sun J, Chang B, et al. Interleukin-1
receptor antagonist haplotype associated with prostate cancer risk. Br J Cancer.
2005;93(4):493-7.
Lindstrom S, Wiklund F, Jonsson BA, Adami HO, Balter K, Brookes AJ, et al.
Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate
cancer risk: strong confirmation of functional promoter SNP. Hum Genet. 2005;118(34):339-47.
Sun J, Wiklund F, Zheng SL, Chang B, Balter K, Li L, et al. Sequence variants in Tolllike receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer
Inst. 2005;97(7):525-32.
Suriano G, Yew S, Ferreira P, Senz J, Kaurah P, Ford JM, et al. Characterization of a
recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and
clinical management. Clin Cancer Res. 2005;11(15):5401-9.
Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, et al. A combined
genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes
conducted by the international consortium for prostate cancer genetics. Am J Hum Genet.
2005;77(2):219-29.
Xu J, Lowey J, Wiklund F, Sun J, Lindmark F, Hsu FC, et al. The interaction of four
genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer
Epidemiol Biomarkers Prev. 2005;14(11 Pt 1):2563-8.
Alexeyev O, Bergh J, Marklund I, Thellenberg-Karlsson C, Wiklund F, Gronberg H, et
al. Association between the presence of bacterial 16S RNA in prostate specimens taken
during transurethral resection of prostate and subsequent risk of prostate cancer
(Sweden). Cancer Causes Control. 2006;17(9):1127-33.
Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al.
A common variant associated with prostate cancer in European and African populations.
Nat Genet. 2006;38(6):652-8.
Chang BL, Lange EM, Dimitrov L, Valis CJ, Gillanders EM, Lange LA, et al. Two-locus
genome-wide linkage scan for prostate cancer susceptibility genes with an interaction
effect. Hum Genet. 2006;118(6):716-24.
Hedelin M, Balter KA, Chang ET, Bellocco R, Klint A, Johansson JE, et al. Dietary
intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate
cancer. Prostate. 2006;66(14):1512-20.
Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO, et al. Dietary
phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate
Sweden study (Sweden). Cancer Causes Control. 2006;17(2):169-80.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
Kanter-Smoler G, Bjork J, Fritzell K, Engwall Y, Hallberg B, Karlsson G, et al. Novel
findings in Swedish patients with MYH-associated polyposis: mutation detection and
clinical characterization. Clin Gastroenterol Hepatol. 2006;4(4):499-506.
Karlsson CT, Malmer B, Wiklund F, Gronberg H. Breast cancer as a second primary in
patients with prostate cancer--estrogen treatment or association with family history of
cancer? J Urol. 2006;176(2):538-43.
Lindstrom S, Wiklund F, Adami HO, Balter KA, Adolfsson J, Gronberg H. Germ-line
genetic variation in the key androgen-regulating genes androgen receptor, cytochrome
P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
Cancer Res. 2006;66(22):11077-83.
Lindstrom S, Zheng SL, Wiklund F, Jonsson BA, Adami HO, Balter KA, et al.
Systematic replication study of reported genetic associations in prostate cancer: Strong
support for genetic variation in the androgen pathway. Prostate. 2006;66(16):1729-43.
Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, et
al. Pooled genome linkage scan of aggressive prostate cancer: results from the
International Consortium for Prostate Cancer Genetics. Hum Genet. 2006;120(4):471-85.
Shahedi K, Emanuelsson M, Wiklund F, Gronberg H. High risk of contralateral breast
carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
Cancer. 2006;106(6):1237-42.
Shahedi K, Lindstrom S, Zheng SL, Wiklund F, Adolfsson J, Sun J, et al. Genetic
variation in the COX-2 gene and the association with prostate cancer risk. Int J Cancer.
2006;119(3):668-72.
Sun J, Wiklund F, Hsu FC, Balter K, Zheng SL, Johansson JE, et al. Interactions of
sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 61-10 gene cluster increase prostate cancer risk. Cancer Epidemiol Biomarkers Prev.
2006;15(3):480-5.
Thellenberg-Karlsson C, Lindstrom S, Malmer B, Wiklund F, Augustsson-Balter K,
Adami HO, et al. Estrogen receptor beta polymorphism is associated with prostate cancer
risk. Clin Cancer Res. 2006;12(6):1936-41.
Zheng SL, Liu W, Wiklund F, Dimitrov L, Balter K, Sun J, et al. A comprehensive
association study for genes in inflammation pathway provides support for their roles in
prostate cancer risk in the CAPS study. Prostate. 2006;66(14):1556-64.
Bergh J, Marklund I, Gustavsson C, Wiklund F, Gronberg H, Allard A, et al. No link
between viral findings in the prostate and subsequent cancer development. Br J Cancer.
2007;96(1):137-9.
Bergh J, Marklund I, Thellenberg-Karlsson C, Gronberg H, Elgh F, Alexeyev OA.
Detection of Escherichia coli 16S RNA and cytotoxic necrotizing factor 1 gene in benign
prostate hyperplasia. European urology. 2007;51(2):457-62; discussion 62-3.
Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, et
al. Compelling evidence for a prostate cancer gene at 22q12.3 by the International
Consortium for Prostate Cancer Genetics. Human molecular genetics. 2007;16(11):12718.
De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, et al. Inflammation
in prostate carcinogenesis. Nature reviews. 2007;7(4):256-69.
Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, et al. Two
genome-wide association studies of aggressive prostate cancer implicate putative prostate
tumor suppressor gene DAB2IP. J Natl Cancer Inst. 2007;99(24):1836-44.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
Hedelin M, Chang ET, Wiklund F, Bellocco R, Klint A, Adolfsson J, et al. Association of
frequent consumption of fatty fish with prostate cancer risk is modified by COX-2
polymorphism. Int J Cancer. 2007;120(2):398-405.
Johansson M, McKay JD, Stattin P, Canzian F, Boillot C, Wiklund F, et al.
Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate
cancer. Int J Cancer. 2007;120(3):539-42.
Johansson M, McKay JD, Wiklund F, Rinaldi S, Verheus M, van Gils CH, et al.
Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation
and circulating IGF-I levels. The Journal of clinical endocrinology and metabolism.
2007;92(12):4820-6.
Johansson M, Van Guelpen B, Hultdin J, Wiklund F, Adami HO, Balter K, et al. The
MTHFR 677C --> T polymorphism and risk of prostate cancer: results from the CAPS
study. Cancer Causes Control. 2007;18(10):1169-74.
Lindstrom LS, Hall P, Hartman M, Wiklund F, Gronberg H, Czene K. Familial
concordance in cancer survival: a Swedish population-based study. Lancet Oncol.
2007;8(11):1001-6.
Lindstrom S, Adami HO, Balter KA, Xu J, Zheng SL, Stattin P, et al. Inherited variation
in hormone-regulating genes and prostate cancer survival. Clin Cancer Res.
2007;13(17):5156-61.
Malmer BS, Feychting M, Lonn S, Lindstrom S, Gronberg H, Ahlbom A, et al. Genetic
variation in p53 and ATM haplotypes and risk of glioma and meningioma. Journal of
neuro-oncology. 2007;82(3):229-37.
McKay JD, Kaaks R, Johansson M, Biessy C, Wiklund F, Balter K, et al. Haplotypebased analysis of common variation in the growth hormone receptor gene and prostate
cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16(1):169-73.
Sahlin P, Windh P, Lauritzen C, Emanuelsson M, Gronberg H, Stenman G. Women with
Saethre-Chotzen syndrome are at increased risk of breast cancer. Genes Chromosomes
Cancer. 2007;46(7):656-60.
Sun J, Turner A, Xu J, Gronberg H, Isaacs W. Genetic variability in inflammation
pathways and prostate cancer risk. Urologic oncology. 2007;25(3):250-9.
Torniainen S, Hedelin M, Autio V, Rasinpera H, Balter KA, Klint A, et al. Lactase
persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and
Finland. Cancer Epidemiol Biomarkers Prev. 2007;16(5):956-61.
von Wachenfeldt A, Lindblom A, South Swedish Oncogenetic Study G, Gronberg H,
Einbeigi Z, Rosenquist R, et al. A hypothesis-generating search for new genetic breast
cancer syndromes--a national study in 803 Swedish families. Hered Cancer Clin Pract.
2007;5(1):17-24.
Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, et al. Association between two
unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer
Inst. 2007;99(20):1525-33.
Ahvenainen T, Lehtonen HJ, Lehtonen R, Vahteristo P, Aittomaki K, Baynam G, et al.
Mutation screening of fumarate hydratase by multiplex ligation-dependent probe
amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell
cancer. Cancer genetics and cytogenetics. 2008;183(2):83-8.
Chen SH, Sun J, Dimitrov L, Turner AR, Adams TS, Meyers DA, et al. A support vector
machine approach for detecting gene-gene interaction. Genet Epidemiol. 2008;32(2):15267.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
Cooper ML, Adami HO, Gronberg H, Wiklund F, Green FR, Rayman MP. Interaction
between single nucleotide polymorphisms in selenoprotein P and mitochondrial
superoxide dismutase determines prostate cancer risk. Cancer Res. 2008;68(24):10171-7.
Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, et
al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate
cancer. Nat Genet. 2008;40(3):281-3.
Hassler S, Sjolander P, Gronberg H, Johansson R, Damber L. Cancer in the Sami
population of Sweden in relation to lifestyle and genetic factors. European journal of
epidemiology. 2008;23(4):273-80.
Hsu FC, Lindstrom S, Sun J, Wiklund F, Chen SH, Adami HO, et al. A multigenic
approach to evaluating prostate cancer risk in a systematic replication study. Cancer
genetics and cytogenetics. 2008;183(2):94-8.
Kanter-Smoler G, Fritzell K, Rohlin A, Engwall Y, Hallberg B, Bergman A, et al.
Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis
families. BMC medicine. 2008;6:10.
Lange EM, Sun J, Lange LA, Zheng SL, Duggan D, Carpten JD, et al. Family-based
samples can play an important role in genetic association studies. Cancer Epidemiol
Biomarkers Prev. 2008;17(9):2208-14.
Olsson M, Lindstrom S, Haggkvist B, Adami HO, Balter K, Stattin P, et al. The
UGT2B17 gene deletion is not associated with prostate cancer risk. Prostate.
2008;68(5):571-5.
Strawbridge RJ, Nister M, Brismar K, Gronberg H, Li C. MUC1 as a Putative Prognostic
Marker for Prostate Cancer. Biomark Insights. 2008;3:303-15.
Sun J, Chang BL, Isaacs SD, Wiley KE, Wiklund F, Stattin P, et al. Cumulative effect of
five genetic variants on prostate cancer risk in multiple study populations. Prostate.
2008;68(12):1257-62.
Sun J, Lange EM, Isaacs SD, Liu W, Wiley KE, Lange L, et al. Chromosome 8q24 risk
variants in hereditary and non-hereditary prostate cancer patients. Prostate.
2008;68(5):489-97.
Sun J, Purcell L, Gao Z, Isaacs SD, Wiley KE, Hsu FC, et al. Association between
sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African
Americans. Prostate. 2008;68(7):691-7.
Sun J, Zheng SL, Wiklund F, Isaacs SD, Purcell LD, Gao Z, et al. Evidence for two
independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet.
2008;40(10):1153-5.
Wiklund F, Lageros YT, Chang E, Balter K, Johansson JE, Adami HO, et al. Lifetime
total physical activity and prostate cancer risk: a population-based case-control study in
Sweden. European journal of epidemiology. 2008;23(11):739-46.
Xu J, Isaacs SD, Sun J, Li G, Wiley KE, Zhu Y, et al. Association of prostate cancer risk
variants with clinicopathologic characteristics of the disease. Clin Cancer Res.
2008;14(18):5819-24.
Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, et al. Cumulative association of
five genetic variants with prostate cancer. N Engl J Med. 2008;358(9):910-9.
Bergman A, Sahlin P, Emanuelsson M, Caren H, Tarnow P, Martinsson T, et al.
Germline mutation screening of the Saethre-Chotzen-associated genes TWIST1 and
FGFR3 in families with BRCA1/2-negative breast cancer. Scand J Plast Reconstr Surg
Hand Surg. 2009;43(5):251-5.
129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
Brown DA, Lindmark F, Stattin P, Balter K, Adami HO, Zheng SL, et al. Macrophage
inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res.
2009;15(21):6658-64.
Chang BL, Cramer SD, Wiklund F, Isaacs SD, Stevens VL, Sun J, et al. Fine mapping
association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal
variant for prostate cancer risk. Human molecular genetics. 2009;18(7):1368-75.
Cnattingius S, Lundberg F, Sandin S, Gronberg H, Iliadou A. Birth characteristics and
risk of prostate cancer: the contribution of genetic factors. Cancer Epidemiol Biomarkers
Prev. 2009;18(9):2422-6.
Halthur C, Johansson AL, Almquist M, Malm J, Gronberg H, Manjer J, et al. Serum
calcium and the risk of prostate cancer. Cancer Causes Control. 2009;20(7):1205-14.
Hsu FC, Sun J, Wiklund F, Isaacs SD, Wiley KE, Purcell LD, et al. A novel prostate
cancer susceptibility locus at 19q13. Cancer Res. 2009;69(7):2720-3.
Johansson M, McKay JD, Rinaldi S, Wiklund F, Adami HO, Gronberg H, et al. Genetic
and plasma variation of insulin-like growth factor binding proteins in relation to prostate
cancer incidence and survival. Prostate. 2009;69(12):1281-91.
Johansson M, McKay JD, Wiklund F, Rinaldi S, Hallmans G, Balter K, et al. Genetic
variation in the SST gene and its receptors in relation to circulating levels of insulin-like
growth factor-I, IGFBP3, and prostate cancer risk. Cancer Epidemiol Biomarkers Prev.
2009;18(5):1644-50.
Lindstrom S, Adami HO, Balter K, Xu J, Zheng SL, Sun J, et al. Genetic variation in the
upstream region of ERG and prostate cancer. Cancer Causes Control. 2009;20(7):117380.
Liu W, Sun J, Li G, Zhu Y, Zhang S, Kim ST, et al. Association of a germ-line copy
number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res.
2009;69(6):2176-9.
Lu L, Sun J, Isaacs SD, Wiley KE, Smith S, Pruett K, et al. Fine-mapping and familybased association analyses of prostate cancer risk variants at Xp11. Cancer Epidemiol
Biomarkers Prev. 2009;18(7):2132-6.
Stark JR, Wiklund F, Gronberg H, Schumacher F, Sinnott JA, Stampfer MJ, et al. Tolllike receptor signaling pathway variants and prostate cancer mortality. Cancer Epidemiol
Biomarkers Prev. 2009;18(6):1859-63.
Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, Wiley KE, et al. Sequence variants at
22q13 are associated with prostate cancer risk. Cancer Res. 2009;69(1):10-5.
Wiklund F, Zheng SL, Sun J, Adami HO, Lilja H, Hsu FC, et al. Association of reported
prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate
cancer. Prostate. 2009;69(4):419-27.
Wiklund FE, Adami HO, Zheng SL, Stattin P, Isaacs WB, Gronberg H, et al. Established
prostate cancer susceptibility variants are not associated with disease outcome. Cancer
Epidemiol Biomarkers Prev. 2009;18(5):1659-62.
Wilson KM, Balter K, Adami HO, Gronberg H, Vikstrom AC, Paulsson B, et al.
Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct
levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study. Int J
Cancer. 2009;124(10):2384-90.
Xu J, Sun J, Kader AK, Lindstrom S, Wiklund F, Hsu FC, et al. Estimation of absolute
risk for prostate cancer using genetic markers and family history. Prostate.
2009;69(14):1565-72.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.
159.
Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, et al.
Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat
Genet. 2009;41(10):1055-7.
Zheng SL, Stevens VL, Wiklund F, Isaacs SD, Sun J, Smith S, et al. Two independent
prostate cancer risk-associated Loci at 11q13. Cancer Epidemiol Biomarkers Prev.
2009;18(6):1815-20.
Zheng SL, Sun J, Wiklund F, Gao Z, Stattin P, Purcell LD, et al. Genetic variants and
family history predict prostate cancer similar to prostate-specific antigen. Clin Cancer
Res. 2009;15(3):1105-11.
Altman D, Yin L, Johansson A, Lundholm C, Gronberg H. Risk of renal cell carcinoma
after hysterectomy. Arch Intern Med. 2010;170(22):2011-6.
Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD,
et al. Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the
International Consortium for Prostate Cancer Genetics using novel sumLINK and
sumLOD analyses. Prostate. 2010;70(7):735-44.
Elliott KS, Zeggini E, McCarthy MI, Gudmundsson J, Sulem P, Stacey SN, et al.
Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis
of data from 19 genome-wide association studies. PLoS One. 2010;5(5):e10858.
Hsu FC, Sun J, Zhu Y, Kim ST, Jin T, Zhang Z, et al. Comparison of two methods for
estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and
family history. Cancer Epidemiol Biomarkers Prev. 2010;19(4):1083-8.
Klein RJ, Hallden C, Cronin AM, Ploner A, Wiklund F, Bjartell AS, et al. Blood
biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms:
kallikreins and prostate cancer. Cancer Prev Res (Phila). 2010;3(5):611-9.
Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, et al.
Hundreds of variants clustered in genomic loci and biological pathways affect human
height. Nature. 2010;467(7317):832-8.
Leu M, Humphreys K, Surakka I, Rehnberg E, Muilu J, Rosenstrom P, et al. NordicDB: a
Nordic pool and portal for genome-wide control data. Eur J Hum Genet.
2010;18(12):1322-6.
Lindstrom S, Hunter DJ, Gronberg H, Stattin P, Wiklund F, Xu J, et al. Sequence variants
in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled
analysis from three independent studies. Cancer Epidemiol Biomarkers Prev.
2010;19(3):873-6.
Prokunina-Olsson L, Fu YP, Tang W, Jacobs KB, Hayes RB, Kraft P, et al. Refining the
prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2.
Cancer Epidemiol Biomarkers Prev. 2010;19(5):1349-55.
Reynolds CA, Hong MG, Eriksson UK, Blennow K, Wiklund F, Johansson B, et al.
Analysis of lipid pathway genes indicates association of sequence variation near
SREBF1/TOM1L2/ATPAF2 with dementia risk. Human molecular genetics.
2010;19(10):2068-78.
Schwenk JM, Igel U, Neiman M, Langen H, Becker C, Bjartell A, et al. Toward next
generation plasma profiling via heat-induced epitope retrieval and array-based assays.
Mol Cell Proteomics. 2010;9(11):2497-507.
Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al.
Association analyses of 249,796 individuals reveal 18 new loci associated with body
mass index. Nat Genet. 2010;42(11):937-48.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.
171.
172.
173.
174.
175.
Wiklund FE, Bennet AM, Magnusson PK, Eriksson UK, Lindmark F, Wu L, et al.
Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality.
Aging Cell. 2010;9(6):1057-64.
Vikstrom AC, Wilson KM, Paulsson B, Athanassiadis I, Gronberg H, Adami HO, et al.
Alcohol influence on acrylamide to glycidamide metabolism assessed with hemoglobinadducts and questionnaire data. Food Chem Toxicol. 2010;48(3):820-4.
Xu J, Zheng SL, Isaacs SD, Wiley KE, Wiklund F, Sun J, et al. Inherited genetic variant
predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci U S A.
2010;107(5):2136-40.
Aly M, Wiklund F, Gronberg H. Early detection of prostate cancer with emphasis on
genetic markers. Acta Oncol. 2011;50 Suppl 1:18-23.
Aly M, Wiklund F, Xu J, Isaacs WB, Eklund M, D'Amato M, et al. Polygenic risk score
improves prostate cancer risk prediction: results from the Stockholm-1 cohort study.
European urology. 2011;60(1):21-8.
Berndt SI, Sampson J, Yeager M, Jacobs KB, Wang Z, Hutchinson A, et al. Large-scale
fine mapping of the HNF1B locus and prostate cancer risk. Human molecular genetics.
2011;20(16):3322-9.
Chung CC, Ciampa J, Yeager M, Jacobs KB, Berndt SI, Hayes RB, et al. Fine mapping
of a region of chromosome 11q13 reveals multiple independent loci associated with risk
of prostate cancer. Human molecular genetics. 2011;20(14):2869-78.
Feng J, Sun J, Kim ST, Lu Y, Wang Z, Zhang Z, et al. A genome-wide survey over the
ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel
prostate cancer susceptibility locus at 12q13.13. Cancer Epidemiol Biomarkers Prev.
2011;20(11):2396-403.
Humphreys K, Grankvist A, Leu M, Hall P, Liu J, Ripatti S, et al. The genetic structure
of the Swedish population. PLoS One. 2011;6(8):e22547.
Jin G, Sun J, Liu W, Zhang Z, Chu LW, Kim ST, et al. Genome-wide copy-number
variation analysis identifies common genetic variants at 20p13 associated with
aggressiveness of prostate cancer. Carcinogenesis. 2011;32(7):1057-62.
Karlsson CT, Wiklund F, Gronberg H, Bergh A, Melin B. Risk of Prostate Cancer after
Trans Urethral Resection of BPH: A Cohort and Nested Case-Control Study. Cancers
(Basel). 2011;3(4):4127-38.
Ketabi Z, Bartuma K, Bernstein I, Malander S, Gronberg H, Bjorck E, et al. Ovarian
cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial
tumors. Gynecol Oncol. 2011;121(3):462-5.
Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, et al. Seven
prostate cancer susceptibility loci identified by a multi-stage genome-wide association
study. Nat Genet. 2011;43(8):785-91.
Lin DW, FitzGerald LM, Fu R, Kwon EM, Zheng SL, Kolb S, et al. Genetic variants in
the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate
cancer-specific mortality. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1928-36.
Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, Jameson C, et al. Targeted
prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects
aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU
Int. 2011;107(1):28-39.
Schumacher FR, Berndt SI, Siddiq A, Jacobs KB, Wang Z, Lindstrom S, et al. Genomewide association study identifies new prostate cancer susceptibility loci. Human
molecular genetics. 2011;20(19):3867-75.
176.
177.
178.
179.
180.
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
Sun J, Kader AK, Hsu FC, Kim ST, Zhu Y, Turner AR, et al. Inherited genetic markers
discovered to date are able to identify a significant number of men at considerably
elevated risk for prostate cancer. Prostate. 2011;71(4):421-30.
Westerlund A, Steineck G, Balter K, Stattin P, Gronberg H, Hedelin M. Dietary
supplement use patterns in men with prostate cancer: the Cancer Prostate Sweden study.
Ann Oncol. 2011;22(4):967-72.
Xie CC, Lu L, Sun J, Zheng SL, Isaacs WB, Gronberg H, et al. Germ-line sequence
variants of PTEN do not have an important role in hereditary and non-hereditary prostate
cancer susceptibility. J Hum Genet. 2011;56(7):496-502.
Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, et al. Analysis of
Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG)
families. BMC medical genetics. 2012;13:46.
Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, et al. Validation of prostate
cancer risk-related loci identified from genome-wide association studies using familybased association analysis: evidence from the International Consortium for Prostate
Cancer Genetics (ICPCG). Hum Genet. 2012;131(7):1095-103.
Kim JW, Kim ST, Turner AR, Young T, Smith S, Liu W, et al. Identification of new
differentially methylated genes that have potential functional consequences in prostate
cancer. PLoS One. 2012;7(10):e48455.
Liu W, Lindberg J, Sui G, Luo J, Egevad L, Li T, et al. Identification of novel CHD1associated collaborative alterations of genomic structure and functional assessment of
CHD1 in prostate cancer. Oncogene. 2012;31(35):3939-48.
Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, et al.
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate
cancer families collected by the ICPCG. Prostate. 2012;72(4):410-26.
Lu Y, Sun J, Kader AK, Kim ST, Kim JW, Liu W, et al. Association of prostate cancer
risk with SNPs in regions containing androgen receptor binding sites captured by ChIPOn-chip analyses. Prostate. 2012;72(4):376-85.
Moller E, Galeone C, Adami HO, Adolfsson J, Andersson TM, Bellocco R, et al. The
Nordic Nutrition Recommendations and prostate cancer risk in the Cancer of the Prostate
in Sweden (CAPS) study. Public Health Nutr. 2012;15(10):1897-908.
Neiman M, Sundling S, Gronberg H, Hall P, Czene K, Lindberg J, et al. Library
preparation and multiplex capture for massive parallel sequencing applications made
efficient and easy. PLoS One. 2012;7(11):e48616.
Sooriakumaran P, Haendler L, Nyberg T, Gronberg H, Nilsson A, Carlsson S, et al.
Biochemical recurrence after robot-assisted radical prostatectomy in a European singlecentre cohort with a minimum follow-up time of 5 years. European urology.
2012;62(5):768-74.
Szulkin R, Holmberg E, Stattin P, Xu J, Zheng S, Palmgren J, et al. Prostate cancer risk
variants are not associated with disease progression. Prostate. 2012;72(1):30-9.
Tao S, Wang Z, Feng J, Hsu FC, Jin G, Kim ST, et al. A genome-wide search for loci
interacting with known prostate cancer risk-associated genetic variants. Carcinogenesis.
2012;33(3):598-603.
Xu J, Mo Z, Ye D, Wang M, Liu F, Jin G, et al. Genome-wide association study in
Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat
Genet. 2012;44(11):1231-5.
191.
192.
193.
194.
195.
196.
197.
198.
199.
200.
201.
202.
203.
204.
205.
Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, Chasman DI, et al. FTO
genotype is associated with phenotypic variability of body mass index. Nature.
2012;490(7419):267-72.
Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, et
al. A meta-analysis of genome-wide association studies to identify prostate cancer
susceptibility loci associated with aggressive and non-aggressive disease. Human
molecular genetics. 2013;22(2):408-15.
Barbieri CE, Bangma CH, Bjartell A, Catto JW, Culig Z, Gronberg H, et al. The
mutational landscape of prostate cancer. European urology. 2013;64(4):567-76.
Berndt SI, Gustafsson S, Magi R, Ganna A, Wheeler E, Feitosa MF, et al. Genome-wide
meta-analysis identifies 11 new loci for anthropometric traits and provides insights into
genetic architecture. Nat Genet. 2013;45(5):501-12.
Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M,
et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom
genotyping array. Nat Genet. 2013;45(4):385-91, 91e1-2.
Hong MG, Karlsson R, Magnusson PK, Lewis MR, Isaacs W, Zheng LS, et al. A
genome-wide assessment of variability in human serum metabolism. Human mutation.
2013;34(3):515-24.
Jin G, Zheng SL, Lilja H, Kim ST, Tao S, Gao Z, et al. Genome-wide association study
identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.
Neoplasia. 2013;15(1):95-101.
Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T,
Jugurnauth-Little S, et al. Fine-mapping identifies multiple prostate cancer risk loci at
5p15, one of which associates with TERT expression. Human molecular genetics.
2013;22(12):2520-8.
Lindberg J, Klevebring D, Liu W, Neiman M, Xu J, Wiklund P, et al. Exome sequencing
of prostate cancer supports the hypothesis of independent tumour origins. European
urology. 2013;63(2):347-53.
Lindberg J, Mills IG, Klevebring D, Liu W, Neiman M, Xu J, et al. The mitochondrial
and autosomal mutation landscapes of prostate cancer. European urology.
2013;63(4):702-8.
Liu W, Xie CC, Thomas CY, Kim ST, Lindberg J, Egevad L, et al. Genetic markers
associated with early cancer-specific mortality following prostatectomy. Cancer.
2013;119(13):2405-12.
Moller E, Adami HO, Mucci LA, Lundholm C, Bellocco R, Johansson JE, et al. Lifetime
body size and prostate cancer risk in a population-based case-control study in Sweden.
Cancer Causes Control. 2013;24(12):2143-55.
Moller E, Galeone C, Andersson TM, Bellocco R, Adami HO, Andren O, et al.
Mediterranean Diet Score and prostate cancer risk in a Swedish population-based casecontrol study. Journal of nutritional science. 2013;2:e15.
Nordstrom T, Aly M, Clements MS, Weibull CE, Adolfsson J, Gronberg H. Prostatespecific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden,
Despite no recommendations for PSA screening: results from a population-based study,
2003-2011. European urology. 2013;63(3):419-25.
Nordstrom T, Clements MS, Adolfsson J, Gronberg H. Reply from Authors re: Goutham
Vemana, Gerald L. Andriole. Bad Habits May Be Hard to Break. Eur Urol 2013;63:4267: Changing Habits. European urology. 2013;63(3):427.
206.
207.
208.
209.
210.
211.
212.
213.
214.
215.
216.
217.
218.
219.
220.
Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL, et al. Sexstratified genome-wide association studies including 270,000 individuals show sexual
dimorphism in genetic loci for anthropometric traits. PLoS genetics. 2013;9(6):e1003500.
Rietveld CA, Medland SE, Derringer J, Yang J, Esko T, Martin NW, et al. GWAS of
126,559 individuals identifies genetic variants associated with educational attainment.
Science. 2013;340(6139):1467-71.
Wilson KM, Balter K, Moller E, Adami HO, Andren O, Andersson SO, et al. Coffee and
risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden
Study. Cancer Causes Control. 2013;24(8):1575-81.
Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, et al. HOXB13 is a
susceptibility gene for prostate cancer: results from the International Consortium for
Prostate Cancer Genetics (ICPCG). Hum Genet. 2013;132(1):5-14.
Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, et al. A metaanalysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.
Nat Genet. 2014;46(10):1103-9.
Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, et al. Targeted prostate
cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial
screening round of the IMPACT study. European urology. 2014;66(3):489-99.
Bonn SE, Wiklund F, Sjolander A, Szulkin R, Stattin P, Holmberg E, et al. Body mass
index and weight change in men with prostate cancer: progression and mortality. Cancer
Causes Control. 2014;25(8):933-43.
Genovese G, Kahler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al.
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J
Med. 2014;371(26):2477-87.
Karlsson R, Aly M, Clements M, Zheng L, Adolfsson J, Xu J, et al. A population-based
assessment of germline HOXB13 G84E mutation and prostate cancer risk. European
urology. 2014;65(1):169-76.
Klevebring D, Neiman M, Sundling S, Eriksson L, Darai Ramqvist E, Celebioglu F, et al.
Evaluation of exome sequencing to estimate tumor burden in plasma. PLoS One.
2014;9(8):e104417.
Kristensen H, Haldrup C, Strand S, Mundbjerg K, Mortensen MM, Thorsen K, et al.
Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer
predicts biochemical recurrence after radical prostatectomy. Clin Cancer Res.
2014;20(8):2169-81.
Nordstrom T, Aly M, Eklund M, Egevad L, Gronberg H. A genetic score can identify
men at high risk for prostate cancer among men with prostate-specific antigen of 1-3
ng/ml. European urology. 2014;65(6):1184-90.
Nyren O, Stenbeck M, Gronberg H. The European Parliament proposal for the new EU
General Data Protection Regulation may severely restrict European epidemiological
research. European journal of epidemiology. 2014;29(4):227-30.
Saunders EJ, Dadaev T, Leongamornlert DA, Jugurnauth-Little S, Tymrakiewicz M,
Wiklund F, et al. Fine-mapping the HOXB region detects common variants tagging a rare
coding allele: evidence for synthetic association in prostate cancer. PLoS genetics.
2014;10(2):e1004129.
Seipel AH, Samaratunga H, Delahunt B, Wiklund F, Wiklund P, Lindberg J, et al.
Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Archiv
: an international journal of pathology. 2014;465(5):559-65.
221.
222.
223.
224.
225.
226.
227.
228.
229.
230.
231.
232.
233.
234.
235.
236.
Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, et al.
Association analysis of 9,560 prostate cancer cases from the International Consortium of
Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs
for familial disease. Hum Genet. 2014;133(3):347-56.
Whitaker HC, Shiong LL, Kay JD, Gronberg H, Warren AY, Seipel A, et al. N-acetyl-Laspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a promigratory and pro-metastatic phenotype. Oncogene. 2014;33(45):5274-87.
Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, et al. Defining the role
of common variation in the genomic and biological architecture of adult human height.
Nat Genet. 2014;46(11):1173-86.
Aly M, Dyrdak R, Nordstrom T, Jalal S, Weibull CE, Giske CG, et al. Rapid increase in
multidrug-resistant enteric bacilli blood stream infection after prostate biopsy - A 10-year
population-based cohort study. Prostate. 2015;75(9):947-56.
Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, et al.
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known
risk loci among Europeans. Human molecular genetics. 2015;24(19):5589-602.
Berndt SI, Wang Z, Yeager M, Alavanja MC, Albanes D, Amundadottir L, et al. Two
susceptibility loci identified for prostate cancer aggressiveness. Nature communications.
2015;6:6889.
Bollineni RC, Guldvik IJ, Gronberg H, Wiklund F, Mills IG, Thiede B. A differential
protein solubility approach for the depletion of highly abundant proteins in plasma using
ammonium sulfate. Analyst. 2015;140(24):8109-17.
Bonn SE, Sjolander A, Lagerros YT, Wiklund F, Stattin P, Holmberg E, et al. Physical
activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol
Biomarkers Prev. 2015;24(1):57-64.
Cantarutti A, Bonn SE, Adami HO, Gronberg H, Bellocco R, Balter K. Body mass index
and mortality in men with prostate cancer. Prostate. 2015;75(11):1129-36.
Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, et al. The effects of
height and BMI on prostate cancer incidence and mortality: a Mendelian randomization
study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer
Causes Control. 2015;26(11):1603-16.
Falconer H, Yin L, Gronberg H, Altman D. Ovarian cancer risk after salpingectomy: a
nationwide population-based study. J Natl Cancer Inst. 2015;107(2).
Gronberg H, Adolfsson J, Aly M, Nordstrom T, Wiklund P, Brandberg Y, et al. Prostate
cancer screening in men aged 50-69 years (STHLM3): a prospective population-based
diagnostic study. Lancet Oncol. 2015;16(16):1667-76.
Han Y, Hazelett DJ, Wiklund F, Schumacher FR, Stram DO, Berndt SI, et al. Integration
of multiethnic fine-mapping and genomic annotation to prioritize candidate functional
SNPs at prostate cancer susceptibility regions. Human molecular genetics.
2015;24(19):5603-18.
Hung RJ, Ulrich CM, Goode EL, Brhane Y, Muir K, Chan AT, et al. Cross Cancer
Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung,
Ovary, Prostate, Breast, and Colorectal Cancer. J Natl Cancer Inst. 2015;107(11).
Lindberg J, Kristiansen A, Wiklund P, Gronberg H, Egevad L. Tracking the origin of
metastatic prostate cancer. European urology. 2015;67(5):819-22.
Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of
body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197206.
237.
238.
239.
240.
241.
242.
243.
244.
245.
246.
247.
248.
249.
250.
251.
252.
Nordstrom T, Clements M, Karlsson R, Adolfsson J, Gronberg H. The risk of prostate
cancer for men on aspirin, statin or antidiabetic medications. Eur J Cancer.
2015;51(6):725-33.
Nordstrom T, Vickers A, Assel M, Lilja H, Gronberg H, Eklund M. Comparison Between
the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.
European urology. 2015;68(1):139-46.
Ross-Adams H, Lamb AD, Dunning MJ, Halim S, Lindberg J, Massie CM, et al.
Integration of copy number and transcriptomics provides risk stratification in prostate
cancer: A discovery and validation cohort study. EBioMedicine. 2015;2(9):1133-44.
Stegeman S, Amankwah E, Klein K, O'Mara TA, Kim D, Lin HY, et al. A Large-Scale
Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer.
Cancer discovery. 2015;5(4):368-79.
Szulkin R, Karlsson R, Whitington T, Aly M, Gronberg H, Eeles RA, et al. Genome-wide
association study of prostate cancer-specific survival. Cancer Epidemiol Biomarkers
Prev. 2015;24(11):1796-800.
Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, Easton D, et al. Prediction of
individual genetic risk to prostate cancer using a polygenic score. Prostate.
2015;75(13):1467-74.
Winkler TW, Justice AE, Graff M, Barata L, Feitosa MF, Chu S, et al. The Influence of
Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale
Genome-Wide Interaction Study. PLoS genetics. 2015;11(10):e1005378.
Zhang C, Doherty JA, Burgess S, Hung RJ, Lindstrom S, Kraft P, et al. Genetic
determinants of telomere length and risk of common cancers: a Mendelian randomization
study. Human molecular genetics. 2015;24(18):5356-66.
Bonn SE, Sjolander A, Tillander A, Wiklund F, Gronberg H, Balter K. Body mass index
in relation to serum prostate-specific antigen levels and prostate cancer risk. Int J Cancer.
2016.
Haldrup C, Lynnerup AS, Storebjerg TM, Vang S, Wild P, Visakorpi T, et al. Large-scale
evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker
potential at three molecular levels. Mol Oncol. 2016.
Jan M, Bonn SE, Sjolander A, Wiklund F, Stattin P, Holmberg E, et al. The roles of stress
and social support in prostate cancer mortality. Scand J Urol. 2016;50(1):47-55.
Koitsalu M, Sprangers MA, Eklund M, Czene K, Hall P, Gronberg H, et al. Public
interest in and acceptability of the prospect of risk-stratified screening for breast and
prostate cancer. Acta Oncol. 2016;55(1):45-51.
Mer AS, Klevebring D, Gronberg H, Rantalainen M. Study design requirements for RNA
sequencing-based breast cancer diagnostics. Sci Rep. 2016;6:20200.
Nordstrom T, Bratt O, Ortegren J, Aly M, Adolfsson J, Gronberg H. A population-based
study on the association between educational length, prostate-specific antigen testing and
use of prostate biopsies. Scand J Urol. 2016;50(2):104-9.
Saunders EJ, Dadaev T, Leongamornlert DA, Olama AA, Benlloch S, Giles GG, et al.
Gene and pathway level analyses of germline DNA-repair gene variants and prostate
cancer susceptibility using the iCOGS-genotyping array. Br J Cancer. 2016.
Whitington T, Gao P, Song W, Ross-Adams H, Lamb AD, Yang Y, et al. Gene
regulatory mechanisms underpinning prostate cancer susceptibility. Nat Genet. 2016.